
Kevin Chan, OD, MS, discusses an AAOpt 2026 symposium on individualized low-dose atropine dosing for myopia and the FDA outlook ahead of the SYD-101 advisory meeting.
From dry eye to GLP-1s, this year's conference brought a variety of insights from key experts in optometry.






